Filter posts

Buy Side Investors Bullish Ahead of 2014 BIO CEO & Investor Conference

2013 was a record year for the biotech sector, with the NASDAQ Biotechnology Index hitting …

BIO CEO: Five Prime Therapeutics Company Snapshot

Five Prime Therapeutics is another company that will be presenting at next week’s BIO CEO …

BIO CEO Company Snapshot: Tetraphase Pharmaceuticals

The BIO CEO & Investor Conference is now just a week away, and buzz for …

BIO CEO Company Snapshot: Conatus Pharmaceuticals

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & …

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Is 2014 a good time to invest in biotech? How many biotech IPOs will there …

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

In just a few weeks, industry leaders will gather in New York for one of …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …

Show Me the Money: Reimbursement in an ACA World

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …

Orphan Drugs: Making Rare Diseases Rarer

A panel at the BIO CEO & Investor Conference provided an analysis of the thriving …

Putting a Ring on It: Advice on Successful Drug Development Collaborations

Drug development partnerships can look lucrative to small biotechs eager to monetize their discoveries, but, …